SCHEMBL5570947

SCHEMBL5570947

O=C(CC(NC(=O)c1ccc(C2(CN3CCCC3)CC2)cc1)c1ccccc1)Nc1ccc(Cl)cn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ UTS2R Q9UKP6 4/20 0.46
▸ ALDH1A1 P00352 1/20 0.45
▸ FPR1 P21462 1/20 0.43
▸ FPR2 P25090 1/20 0.43
▸ F10 P00742 6/20 0.43
▸ ROCK2 O75116 1/20 0.42
▸ ROCK1 Q13464 1/20 0.42
▸ EP300 Q09472 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ CASP3 P42574 1/20 0.41
▸ SENP8 Q96LD8 1/20 0.41
▸ SENP7 Q9BQF6 1/20 0.41
▸ SENP6 Q9GZR1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5566598 0.86 F10 (0.45) HTTNPSR1ALDH1A1FPR1FPR2
SCHEMBL5566012 0.85 F10 (0.44) HTTNPSR1ALDH1A1FPR1FPR2
SCHEMBL5436666 0.80 F10 (0.63) HTTNPSR1UTS2RALDH1A1F10
SCHEMBL5569358 0.80 RAB9A (0.57) ALDH1A1FPR1FPR2F10NPC1
SCHEMBL5672229 0.79 F10 (0.48) HTTFPR1FPR2F10NPC1
SCHEMBL5642247 0.78 F10 (0.67) F10
SCHEMBL5566263 0.78 ROCK1 (0.51) UTS2RF10ROCK2ROCK1KDM4E
SCHEMBL5440656 0.77 F10 (0.60) HTTNPSR1F10KDM4EGAA
SCHEMBL5669901 0.77 MAPK1 (0.47) NPSR1ALDH1A1FPR1FPR2F10
SCHEMBL5672236 0.75 F10 (0.49) ALDH1A1FPR1FPR2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250415-B2 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-07-31 — — US disclosed
EP-1628668-A2 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, BETA-AMINOACIDS, ALPHA-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITO RS Bristol-Myers Squibb Company (US) 2006-03-01 — — EP disclosed
WO-2004108892-A2 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, β-AMINOACIDS, α-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-12-16 — — WO disclosed
Send feedback